TipRanks
Go Ultimate55% OFF

City Therapeutics, Inc. (CTY) Income Statement

City Therapeutics, Inc. Income Statement

Last quarter (Q2 2020), City Therapeutics, Inc.'s total revenue was $524.00M, a decrease of 74.45% from the same quarter last year. In Q2, City Therapeutics, Inc.'s net income was $430.00M. See City Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 19Dec 18Dec 17
$ 8.16B$ 8.49B$ 8.55B
$ 5.72B$ 5.73B$ 5.67B
$ 659.00M$ 5.83B$ 6.24B
Depreciation and Amortization$ 1.36B$ 1.44B$ 1.58B
$ 3.83B$ 4.04B$ 3.84B
$ 2.88B$ 2.66B$ 2.31B
$ -416.00M$ -501.00M$ -522.00M
$ 2.47B$ 2.16B$ 1.79B
$ 1.83B$ 1.67B$ 1.66B
Per Share Metrics
Basic EPS$ 0.00$ 0.00$ 0.00
Diluted EPS$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding000
Weighted Average Shares Outstanding (Diluted)000

Currency in USD

City Therapeutics, Inc. Earnings and Revenue History

03B6B9B19.2 %20.4 %21.6 %22.8 %EarningsProfit Margin201720182019RevenueEarningsProfit Margin